A Weekly Advocacy Message from Mary Woolley: The $6 billion dollar election
Dear Research Advocate,
By far the most expensive, and arguably one of the most divisive, election seasons in history is behind us. A lot of money was spent to find out that Americans continue to hold divergent views on many issues. We heard very little about research during the election because, in most ways, it is not a divisive issue; support is both bipartisan and grounded in common sense. The problem is that it can be taken too much for granted. At a time when Americans are looking for an end to standoff politics and want action on things we can feel good about as a nation, prioritizing research for health can be the perfect healing issue ’ something we can all be proud of. But let’s be clear: Action to prioritize research will only happen if we speak out to put it in the spotlight as policy makers regroup to address the fiscal cliff. We need to convince policy makers that prioritizing research is the smart thing to do as well ’ smart for job creation and to drive the economy, smart for assuring our global competitiveness, smart for patients, and smart for maximizing innovations that will save lives and drive down the cost of health care.
We must unite and speak with one voice that we need cures, not cuts! If you are not already on board our week of advocacy November 12-16, I encourage you to add your organization to our list of partners and engage your networks to participate in the various strategies that are planned, including a call-in day, a day for visits to district offices, an email-in day, and a Hill day entailing visits to a number of DC offices. All these strategies are supported by an inside-the-Beltway advertising campaign designed to get maximum attention. Click here to see the latest schedule of events for the week ahead. If you would like to sign up for the Hill day, have other events that you would like to include in the calendar, or would like more information, contact Ellie Dehoney at email@example.com. As an important part of this effort, we are circulating a sign-on letter urging Congress to prioritize research in a deal averting sequestration or any other plan for addressing the deficit. Read the full letter here, and contact Jordan Gates at firstname.lastname@example.org for an updated list of cosigners and/or to sign on. The deadline is fast approaching ’ be sure to sign today!
Post-election, it is instructive to take a look at the responses of various candidates who responded to Your Candidates’Your Health, our voter education initiative. I recommend taking a quick look at President Obama’s responses here, noting his commitment to doubling funding for federal research agencies. As a sampling of other responses take a look at those of Rep. Dr. Dan Benishek (R-MI), who held his seat, here. In Massachusetts, Joe Kennedy won a seat in the 4th District ’ judging from his responses here, he will be one of our new champions. Medical research champion Brian Bilbray (R-CA) is locked in a not-yet-called election in San Diego. For more on what this election means, be sure to attend our post-election event on November 15th.
I have had the chance to talk about the post-election prospects for research as they impact all the elements of the research enterprise on BioCentury This Week. This program can be viewed here. Maybe you will watch it with a copy of the latest (tomorrow’s) issue of Science magazine in hand. In the lead editorial, AAAS CEO Dr. Alan Leshner and I urge the science community ’ as individuals as well as through their institutions and associations ’ to speak out now to Congress or face the decline of research in this nation. This is not a time to hold back! As you reach out, make use of resources on the website for the Week of Advocacy, www.saveresearch.org, including op-ed and letter-to-the editor templates, sample tweets and a new fact sheet on the economic impact of NIH. There are also links to many extraordinary resources produced by FASEB, UMR, AAAS, Ad Hoc and many other organizations. We thank you all for uniting in saying to Congress and the administration: WE NEED CURES, NOT CUTS!